| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 11th November 2020 | Richard J Berman | 20,000 | Open or private sale | $55.55 | $1,110,934.00 |
| 11th November 2020 | Richard J Berman | 11,700 | Exercise of derivative | $4.56 | $53,352.00 |
| 11th November 2020 | Richard J Berman | 8,300 | Exercise of derivative | $3.07 | $25,481.00 |
| 30th September 2020 | Edward J Zecchini | 192 | Grant/award etc. | $47.82 | $9,181.44 |
| 30th September 2020 | Daniel M Hancock | 240 | Grant/award etc. | $47.82 | $11,476.80 |
| 29th July 2020 | Richard J Berman | 8,138 | Exercise of in-the-money or at-the-money derivatives securities (usually options) | $3.57 | $29,052.66 |
| 20th July 2020 | Robert J Hariri | 15,300 | Exercise of in-the-money or at-the-money derivatives securities (usually options) | $3.57 | $54,621.00 |
| 30th June 2020 | Edward J Zecchini | 310 | Grant/award etc. | $29.54 | $9,157.40 |
| 30th June 2020 | Daniel M Hancock | 389 | Grant/award etc. | $29.54 | $11,491.06 |
| 28th May 2020 | Richard J Berman | 1,112 | Exercise of in-the-money or at-the-money derivatives securities (usually options) | $6.00 | $6,672.00 |
Cryoport
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
Ticker: CYRX
Sector: Industrials
Industry: Integrated Freight & Logistics
SEC Central Index Key (CIK): 1124524
Employees: 92
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
There were no Red Flags found
Fundamentals
Cash at Carrying Value: $44 M (0%)
Inventory, Net: $538 Th (13%)
Assets, Current: $217 M (110%)
Property, Plant and Equipment, Net: $14 M (15%)
Assets: $253 M (0%)
Liabilities, Current: $9 M (72%)
Liabilities: $126 M (1214%)
Common Stock, Value, Issued: $39 Th (3%)
Common Stock, Shares, Issued: $39 M (3%)
Additional Paid in Capital, Common Stock: $295 M (3%)
Retained Earnings (Accumulated Deficit): $169 M (6%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $260 Th (477%)
Stockholders' Equity (Parent): $127 M (0%)
Liabilities and Equity: $253 M (86%)
Gross Margin: $5 M (-50%)
Research and Development: $2 M (-47%)
Sales and Marketing: $3 M (-48%)
General and Administrative Expenses: $6 M (-41%)
Operating Income/Loss: $6 M (0%)
Income before taxes: $6 M (-40%)
Provision for income taxes: $50 Th (-39%)
News
DXP Enterprises Reports Third Quarter 2020 Results
6th November 2020
17 Arrested For Running Fake Call Centre In Delhi: Police
6th November 2020
Ubiquiti Inc. Reports First Quarter Fiscal 2021 Financial Results
6th November 2020